BACKGROUND: Several studies have demonstrated the time course of inflammatory mediators in nasal fluids following nasal allergen challenge (NAC), whereas the effects of NAC on cells in the periphery are unknown. We examined the time course of effector cell markers (for basophils, dendritic cells and T cells) in peripheral blood after nasal grass pollen allergen challenge. METHODS: Twelve participants with seasonal allergic rhinitis underwent a control (diluent) challenge followed by NAC after an interval of 14 days. Nasal symptoms and peak nasal inspiratory flow (PNIF) were recorded along with peripheral basophil, T-cell and dendritic cell responses (flow cytometry), T-cell proliferative responses (thymidine incorporation), and cytokine expression (FluoroSpot assay). RESULTS: Robust increases in nasal symptoms and decreases in PNIF were observed during the early (0-1 h) response and modest significant changes during the late (1-24 h) response. Sequential peaks in peripheral blood basophil activation markers were observed (CD107a at 3 h, CD63 at 6 h, and CD203c(bright) at 24 h). T effector/memory cells (CD4(+) CD25(lo) ) were increased at 6 h and accompanied by increases in CD80(+) and CD86(+) plasmacytoid dendritic cells (pDCs). Ex vivo grass antigen-driven T-cell proliferative responses and the frequency of IL-4(+) CD4(+) T cells were significantly increased at 6 h after NAC when compared to the control day. CONCLUSION: Basophil, T-cell, and dendritic cell activation increased the frequency of allergen-driven IL-4(+) CD4(+) T cells, and T-cell proliferative responses are detectable in the periphery after NAC. These data confirm systemic cellular activation following a local nasal provocation.
BACKGROUND: Several studies have demonstrated the time course of inflammatory mediators in nasal fluids following nasal allergen challenge (NAC), whereas the effects of NAC on cells in the periphery are unknown. We examined the time course of effector cell markers (for basophils, dendritic cells and T cells) in peripheral blood after nasal grass pollen allergen challenge. METHODS: Twelve participants with seasonal allergic rhinitis underwent a control (diluent) challenge followed by NAC after an interval of 14 days. Nasal symptoms and peak nasal inspiratory flow (PNIF) were recorded along with peripheral basophil, T-cell and dendritic cell responses (flow cytometry), T-cell proliferative responses (thymidine incorporation), and cytokine expression (FluoroSpot assay). RESULTS: Robust increases in nasal symptoms and decreases in PNIF were observed during the early (0-1 h) response and modest significant changes during the late (1-24 h) response. Sequential peaks in peripheral blood basophil activation markers were observed (CD107a at 3 h, CD63 at 6 h, and CD203c(bright) at 24 h). T effector/memory cells (CD4(+) CD25(lo) ) were increased at 6 h and accompanied by increases in CD80(+) and CD86(+) plasmacytoid dendritic cells (pDCs). Ex vivo grass antigen-driven T-cell proliferative responses and the frequency of IL-4(+) CD4(+) T cells were significantly increased at 6 h after NAC when compared to the control day. CONCLUSION: Basophil, T-cell, and dendritic cell activation increased the frequency of allergen-driven IL-4(+) CD4(+) T cells, and T-cell proliferative responses are detectable in the periphery after NAC. These data confirm systemic cellular activation following a local nasal provocation.
Authors: David Larson; Piyush Patel; Anne Marie Salapatek; Peter Couroux; Don Whitehouse; Adela Pina; Jacqueline L Johnson; Michelle L Sever; Srinath Sanda; Julian Poyser; Theresa Allio; Guy W Scadding; Tielin Qin; Mohamed H Shamji; William W Kwok; Eddie A James; Deanna French; Alina Lelic; Mark Larché; Matthew C Altman; Alkis Togias; Stephen R Durham Journal: J Allergy Clin Immunol Date: 2020-03-10 Impact factor: 10.793
Authors: Agata Schramm; Barbara Jasiewicz-Honkisz; Grzegorz Osmenda; Grzegorz Wilk; Mateusz Siedlinski; Agnieszka Sagan; Pawel T Matusik; Joanna Maciag; Tomasz Sliwa; Marta Czesnikiewicz-Guzik; Tomasz P Mikolajczyk Journal: Allergy Asthma Clin Immunol Date: 2016-10-24 Impact factor: 3.406
Authors: Peter Korosec; Paul J Turner; Mira Silar; Peter Kopac; Mitja Kosnik; Bernhard F Gibbs; Mohamed H Shamji; Adnan Custovic; Matija Rijavec Journal: J Allergy Clin Immunol Date: 2017-03-22 Impact factor: 10.793
Authors: Siti Muhamad Nur Husna; Norasnieda Md Shukri; Sharifah Emilia Tuan Sharif; Hern Tze Tina Tan; Noor Suryani Mohd Ashari; Kah Keng Wong Journal: Front Mol Biosci Date: 2022-03-17